Clinical Trial Details

EORTC-22863

Back to Clinical Trials Database

Phase III randomized clinical trial in high metastatic risk carcinoma of the prostate comparing pelvic radiotherapy plus LHRH analogue (Jointly with the EORTC Genito-Urinary Cancers Group)

Study documentation

Trial Status All trial activities ended
Dates Date of activation: 01-May-1987
Date Step1 close: 20-Nov-1995
Data management at EORTC Yes
Design Phase 3
Randomized open label
Targeted Sample size EORTC Groups: 300
Treatment
Study Staff
Type of cancer
Participating groups EORTC Genito-Urinary Cancers Group
EORTC Radiation Oncology Group
Protocol summary http://clinicaltrials.gov/ct/show/NCT00849082
NCT number NCT00849082